报名：第十届色谱网络会议（iCC2025）

Core Viewpoint - Chromatography technology is a crucial analytical method driving scientific breakthroughs and industrial upgrades, with advancements in multidimensional, combined, and intelligent applications across various fields such as life sciences, environmental monitoring, food safety, and precision medicine [1][2]. Event Overview - The 10th Chromatography Network Conference (iCC 2025) will be held on September 4-5, 2025, organized by Instrument Information Network in collaboration with the North American Chinese Chromatography Association (CACA) [1][3]. Conference Focus Areas - The conference will feature four main sessions: 1. Cutting-edge technology session focusing on innovative chromatographic methods [1]. 2. Food and environmental applications session addressing new standards and applications in PFAS detection, carbohydrate analysis, and food flavor analysis [1]. 3. Pharmaceutical research session with insights from renowned pharmaceutical scientists on drug development and quality control challenges [1]. 4. Domestic chromatography technology session showcasing breakthroughs from local enterprises [1]. Conference Schedule Highlights - September 4: - Presentations on low-abundance compound analysis, innovative gas chromatography applications, and therapeutic protein drug analysis [4]. - Afternoon sessions on PFAS analysis and new standards for environmental air particulate matter [4]. - September 5: - Focus on pharmaceutical research with discussions on nitrosamine risks in drugs and quality control methods for protein drugs [5]. - A showcase of domestic chromatography technology and applications, highlighting the achievements of local companies [5]. Notable Speakers - The conference will feature experts from various institutions, including: - Professor Feng Yuqi from Wuhan Textile University, specializing in chromatographic applications [7]. - Professor Huang Jun from Tsinghua University, focusing on PFAS analysis methods [8]. - Senior Scientist Nan He from AbbVie, discussing nitrosamine risks in pharmaceuticals [8].